Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Value | Details | |
---|---|---|---|---|---|---|---|---|
2025-01-08 | 2025-01-08 |
Passage Bio Inc
(PASG)
|
S Sale |
75,007
-1.0%
0.68USD 51,005 |
75,007 -1.0% | 0.68 | USD 51,005 | |
2025-01-08 | 2025-01-07 |
Passage Bio Inc
(PASG)
|
S Sale |
52,536
-0.7%
0.71USD 37,301 |
52,536 -0.7% | 0.71 | USD 37,301 | |
2025-01-08 | 2025-01-06 |
Passage Bio Inc
(PASG)
|
S Sale |
19,481
-0.3%
0.77USD 15,000 |
19,481 -0.3% | 0.77 | USD 15,000 | |
2024-12-26 | 2024-12-20 |
Passage Bio Inc
(PASG)
|
S Sale |
230,321
-3.0%
0.60USD 138,193 |
230,321 -3.0% | 0.60 | USD 138,193 | |
2024-12-11 | 2024-12-11 |
Passage Bio Inc
(PASG)
|
S Sale |
80
-0.0%
0.80USD 64 |
80 -0.0% | 0.80 | USD 64 | |
2024-12-11 | 2024-12-10 |
Passage Bio Inc
(PASG)
|
S Sale |
8,015
-0.1%
0.80USD 6,412 |
8,015 -0.1% | 0.80 | USD 6,412 | |
2024-12-11 | 2024-12-09 |
Passage Bio Inc
(PASG)
|
S Sale |
54,181
-0.7%
0.84USD 45,512 |
54,181 -0.7% | 0.84 | USD 45,512 | |
2024-12-06 | 2024-12-06 |
Passage Bio Inc
(PASG)
|
S Sale |
20,903
-0.3%
0.82USD 17,140 |
20,903 -0.3% | 0.82 | USD 17,140 | |
2024-12-06 | 2024-12-04 |
Passage Bio Inc
(PASG)
|
S Sale |
76,200
-1.0%
0.79USD 60,198 |
76,200 -1.0% | 0.79 | USD 60,198 | |
2024-10-17 | 2024-10-15 |
Upstream Bio Inc
(UPB)
|
B Purchase |
660,000
+16.9%
17.00USD 11,220,000 |
660,000 +16.9% | 17.00 | USD 11,220,000 | |
2024-10-17 | 2024-10-15 |
Upstream Bio Inc
(UPB)
|
B Purchase |
165,000
+16.9%
17.00USD 2,805,000 |
165,000 +16.9% | 17.00 | USD 2,805,000 | |
2024-09-23 | 2024-09-19 |
Passage Bio Inc
(PASG)
|
S Sale |
39,300
-0.5%
0.71USD 27,903 |
39,300 -0.5% | 0.71 | USD 27,903 | |
2024-09-18 | 2024-09-18 |
Passage Bio Inc
(PASG)
|
S Sale |
25,631
-0.3%
0.73USD 18,711 |
25,631 -0.3% | 0.73 | USD 18,711 | |
2024-09-18 | 2024-09-17 |
Passage Bio Inc
(PASG)
|
S Sale |
111,400
-1.4%
0.73USD 81,322 |
111,400 -1.4% | 0.73 | USD 81,322 | |
2024-09-18 | 2024-09-16 |
Passage Bio Inc
(PASG)
|
S Sale |
63,100
-0.8%
0.74USD 46,694 |
63,100 -0.8% | 0.74 | USD 46,694 | |
2024-09-17 | 2024-09-16 |
MBX Biosciences Inc
(MBX)
|
B Purchase |
250,000
+61.9%
16.00USD 4,000,000 |
250,000 +61.9% | 16.00 | USD 4,000,000 | |
2024-09-17 | 2024-09-16 |
MBX Biosciences Inc
(MBX)
|
B Purchase |
500,000
+18.8%
16.00USD 8,000,000 |
500,000 +18.8% | 16.00 | USD 8,000,000 | |
2024-08-28 | 2024-08-26 |
Silverback Therapeutics Inc
(SBTX)
|
S Sale |
83,695
-100.0%
13.00USD 1,088,035 |
83,695 -100.0% | 13.00 | USD 1,088,035 | |
2024-08-23 | 2024-08-23 |
Silverback Therapeutics Inc
(SBTX)
|
S Sale |
69,500
-45.4%
13.03USD 905,585 |
69,500 -45.4% | 13.03 | USD 905,585 | |
2024-08-23 | 2024-08-22 |
Silverback Therapeutics Inc
(SBTX)
|
S Sale |
391,482
-71.9%
12.94USD 5,065,777 |
391,482 -71.9% | 12.94 | USD 5,065,777 | |
2024-08-23 | 2024-08-21 |
Silverback Therapeutics Inc
(SBTX)
|
S Sale |
13,300
-2.4%
14.61USD 194,313 |
13,300 -2.4% | 14.61 | USD 194,313 | |
2024-08-23 | 2024-08-21 |
Silverback Therapeutics Inc
(SBTX)
|
S Sale |
394,400
-41.4%
13.52USD 5,332,288 |
394,400 -41.4% | 13.52 | USD 5,332,288 | |
2024-08-15 | 2024-08-13 |
Keros Therapeutics Inc
(KROS)
|
S Sale |
29,400
-19.7%
44.01USD 1,293,894 |
29,400 -19.7% | 44.01 | USD 1,293,894 | |
2024-08-15 | 2024-08-13 |
Keros Therapeutics Inc
(KROS)
|
S Sale |
220,600
-19.7%
44.01USD 9,708,606 |
220,600 -19.7% | 44.01 | USD 9,708,606 | |
2024-08-15 | 2024-08-13 |
scPharmaceuticals Inc
(SCPH)
|
B Purchase |
21,658
+9.4%
4.00USD 86,632 |
21,658 +9.4% | 4.00 | USD 86,632 | |
2024-08-15 | 2024-08-13 |
scPharmaceuticals Inc
(SCPH)
|
B Purchase |
478,342
+9.0%
4.00USD 1,913,368 |
478,342 +9.0% | 4.00 | USD 1,913,368 | |
2024-07-17 | 2024-07-16 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
623
-0.1%
10.00USD 6,230 |
623 -0.1% | 10.00 | USD 6,230 | |
2024-07-17 | 2024-07-16 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
556
-0.0%
10.00USD 5,560 |
556 -0.0% | 10.00 | USD 5,560 | |
2024-07-17 | 2024-07-16 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
4,009
-0.1%
10.00USD 40,090 |
4,009 -0.1% | 10.00 | USD 40,090 | |
2024-07-17 | 2024-07-15 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
6,142
-0.8%
10.00USD 61,420 |
6,142 -0.8% | 10.00 | USD 61,420 | |
2024-07-17 | 2024-07-15 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
5,401
-0.3%
10.00USD 54,010 |
5,401 -0.3% | 10.00 | USD 54,010 | |
2024-07-17 | 2024-07-15 |
Terns Pharmaceuticals Inc
(TERN)
|
S Sale |
39,433
-0.8%
10.00USD 394,330 |
39,433 -0.8% | 10.00 | USD 394,330 | |
2024-07-02 | 2024-07-02 |
TELA Bio Inc
(TELA)
|
S Sale |
36,600
-1.5%
4.54USD 166,164 |
36,600 -1.5% | 4.54 | USD 166,164 | |
2024-07-02 | 2024-07-01 |
TELA Bio Inc
(TELA)
|
S Sale |
13,700
-0.6%
4.68USD 64,116 |
13,700 -0.6% | 4.68 | USD 64,116 | |
2024-07-02 | 2024-06-28 |
TELA Bio Inc
(TELA)
|
S Sale |
378,000
-13.3%
4.74USD 1,791,720 |
378,000 -13.3% | 4.74 | USD 1,791,720 | |
2024-06-20 | 2024-06-17 |
Gemini Therapeutics Inc
(GMTX)
|
B Purchase |
10,986
+4.9%
36.00USD 395,496 |
10,986 +4.9% | 36.00 | USD 395,496 | |
2024-06-20 | 2024-06-17 |
Gemini Therapeutics Inc
(GMTX)
|
B Purchase |
43,944
+4.9%
36.00USD 1,581,984 |
43,944 +4.9% | 36.00 | USD 1,581,984 | |
2024-06-20 | 2024-06-17 |
Gemini Therapeutics Inc
(GMTX)
|
B Purchase |
28,404
+4.9%
36.00USD 1,022,544 |
28,404 +4.9% | 36.00 | USD 1,022,544 | |
2024-05-20 | 2024-05-16 |
Imara Inc
(IMRA)
|
S Sale |
1,000,000
-11.5%
22.14USD 22,140,000 |
1,000,000 -11.5% | 22.14 | USD 22,140,000 | |
2024-05-20 | 2024-05-16 |
Imara Inc
(IMRA)
|
S Sale |
1,000,000
-11.5%
22.14USD 22,140,000 |
1,000,000 -11.5% | 22.14 | USD 22,140,000 | |
2024-05-20 | 2024-05-16 |
Imara Inc
(IMRA)
|
S Sale |
33,300
-11.6%
22.14USD 737,262 |
33,300 -11.6% | 22.14 | USD 737,262 | |
2024-05-20 | 2024-05-16 |
Imara Inc
(IMRA)
|
S Sale |
33,300
-11.6%
22.14USD 737,262 |
33,300 -11.6% | 22.14 | USD 737,262 | |
2024-05-03 | 2024-05-03 |
Neuropace Inc
(NPCE)
|
S Sale |
4,674
-0.1%
14.03USD 65,576 |
4,674 -0.1% | 14.03 | USD 65,576 | |
2024-05-03 | 2024-05-02 |
Neuropace Inc
(NPCE)
|
S Sale |
8,842
-0.3%
14.01USD 123,876 |
8,842 -0.3% | 14.01 | USD 123,876 | |
2024-05-03 | 2024-05-01 |
Neuropace Inc
(NPCE)
|
S Sale |
15,690
-0.5%
14.02USD 219,974 |
15,690 -0.5% | 14.02 | USD 219,974 | |
2024-04-26 | 2024-04-24 |
Neuropace Inc
(NPCE)
|
S Sale |
1,781
-0.1%
14.06USD 25,041 |
1,781 -0.1% | 14.06 | USD 25,041 | |
2024-04-23 | 2024-04-23 |
Neuropace Inc
(NPCE)
|
S Sale |
21,791
-0.6%
14.29USD 311,393 |
21,791 -0.6% | 14.29 | USD 311,393 | |
2024-04-23 | 2024-04-22 |
Neuropace Inc
(NPCE)
|
S Sale |
24,609
-0.7%
14.05USD 345,756 |
24,609 -0.7% | 14.05 | USD 345,756 | |
2024-04-23 | 2024-04-19 |
Neuropace Inc
(NPCE)
|
S Sale |
18,253
-0.5%
14.02USD 255,907 |
18,253 -0.5% | 14.02 | USD 255,907 | |
2024-04-18 | 2024-04-18 |
Neuropace Inc
(NPCE)
|
S Sale |
2,623
-0.1%
14.06USD 36,879 |
2,623 -0.1% | 14.06 | USD 36,879 | |
2024-04-18 | 2024-04-17 |
Neuropace Inc
(NPCE)
|
S Sale |
300
-0.0%
14.15USD 4,245 |
300 -0.0% | 14.15 | USD 4,245 | |
2024-04-18 | 2024-04-16 |
Neuropace Inc
(NPCE)
|
S Sale |
14,069
-0.4%
14.01USD 197,107 |
14,069 -0.4% | 14.01 | USD 197,107 | |
2024-04-15 | 2024-04-12 |
Neuropace Inc
(NPCE)
|
S Sale |
23,101
-0.7%
14.42USD 333,116 |
23,101 -0.7% | 14.42 | USD 333,116 | |
2024-04-15 | 2024-04-11 |
Neuropace Inc
(NPCE)
|
S Sale |
461,899
-11.5%
14.49USD 6,692,917 |
461,899 -11.5% | 14.49 | USD 6,692,917 | |
2024-01-31 | 2024-01-30 |
Arrivent Biopharma Inc
(AVBP)
|
B Purchase |
222,222
+17.2%
18.00USD 3,999,996 |
222,222 +17.2% | 18.00 | USD 3,999,996 | |
2024-01-31 | 2024-01-30 |
Arrivent Biopharma Inc
(AVBP)
|
B Purchase |
222,222
+17.2%
18.00USD 3,999,996 |
222,222 +17.2% | 18.00 | USD 3,999,996 | |
2024-01-26 | 2024-01-25 |
resTORbio, Inc.
(TORC)
|
B Purchase |
1,041,700
+486.1%
2.40USD 2,500,080 |
1,041,700 +486.1% | 2.40 | USD 2,500,080 | |
2024-01-26 | 2024-01-25 |
resTORbio, Inc.
(TORC)
|
B Purchase |
242,200
+32.4%
2.40USD 581,280 |
242,200 +32.4% | 2.40 | USD 581,280 | |
2024-01-26 | 2024-01-25 |
resTORbio, Inc.
(TORC)
|
B Purchase |
1,841,100
+32.4%
2.40USD 4,418,640 |
1,841,100 +32.4% | 2.40 | USD 4,418,640 | |
2024-01-25 | 2024-01-23 |
Edgewise Therapeutics Inc
(EWTX)
|
B Purchase |
454,545
+3.3%
11.00USD 4,999,995 |
454,545 +3.3% | 11.00 | USD 4,999,995 | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
139,166
-34.5%
18.32USD 2,549,521 |
139,166 -34.5% | 18.32 | USD 2,549,521 | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
1,195,683
-34.5%
18.32USD 21,904,913 |
1,195,683 -34.5% | 18.32 | USD 21,904,913 | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
3,128
-0.8%
19.82USD 61,997 |
3,128 -0.8% | 19.82 | USD 61,997 | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
26,872
-0.8%
19.82USD 532,603 |
26,872 -0.8% | 19.82 | USD 532,603 | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
18,922
-4.4%
19.96USD 377,683 |
18,922 -4.4% | 19.96 | USD 377,683 | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
162,576
-4.4%
19.96USD 3,245,017 |
162,576 -4.4% | 19.96 | USD 3,245,017 | |
2023-12-20 | 2023-12-18 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
1,724
-100.0%
59.24USD 102,130 |
1,724 -100.0% | 59.24 | USD 102,130 | |
2023-12-15 | 2023-12-14 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
57,100
-20.3%
56.75USD 3,240,425 |
57,100 -20.3% | 56.75 | USD 3,240,425 | |
2023-12-15 | 2023-12-14 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
147,600
-20.3%
56.75USD 8,376,300 |
147,600 -20.3% | 56.75 | USD 8,376,300 | |
2023-12-15 | 2023-12-14 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
228,500
-20.3%
56.75USD 12,967,375 |
228,500 -20.3% | 56.75 | USD 12,967,375 | |
2023-12-14 | 2023-12-14 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
100
-0.0%
57.73USD 5,773 |
100 -0.0% | 57.73 | USD 5,773 | |
2023-12-14 | 2023-12-14 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
100
-0.0%
57.73USD 5,773 |
100 -0.0% | 57.73 | USD 5,773 | |
2023-12-14 | 2023-12-13 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
14,100
-4.8%
58.56USD 825,696 |
14,100 -4.8% | 58.56 | USD 825,696 | |
2023-12-14 | 2023-12-13 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
36,400
-4.8%
58.56USD 2,131,584 |
36,400 -4.8% | 58.56 | USD 2,131,584 | |
2023-12-14 | 2023-12-13 |
Gemini Therapeutics Inc
(GMTX)
|
S Sale |
56,200
-4.8%
58.56USD 3,291,072 |
56,200 -4.8% | 58.56 | USD 3,291,072 |
// ... existing code ... // ... rest of the file ...